Skip to main content

Published locations for FDA approves venetoclax for CLL with 17p deletion

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves venetoclax for CLL with 17p deletion

User login

  • Reset your password
  • /content/fda-approves-venetoclax-cll-17p-deletion
  • /hematologynews/article/107973/indolent-lymphoma/fda-approves-venetoclax-cll-17p-deletion
  • /internalmedicinenews/article/107973/indolent-lymphoma/fda-approves-venetoclax-cll-17p-deletion
  • /oncologypractice/article/107973/indolent-lymphoma/fda-approves-venetoclax-cll-17p-deletion
  • /hematologynews/nhlhub/article/107973/indolent-lymphoma/fda-approves-venetoclax-cll-17p-deletion
  • /hematology-oncology/article/107973/indolent-lymphoma/fda-approves-venetoclax-cll-17p-deletion
  • /internalmedicine/article/107973/indolent-lymphoma/fda-approves-venetoclax-cll-17p-deletion
  • /b-cell-lymphoma-icymi/article/107973/indolent-lymphoma/fda-approves-venetoclax-cll-17p-deletion